Serological cancer markers

Publisher: Totowa, N.J. : Humana Press
Year: 1992
Tongue: English
Category: Library

⬇ Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis

xv, 536 p. : 24 cm

📜 SIMILAR VOLUMES

Serological Cancer Markers

📁 Serological Cancer Markers

✍ Stewart Sell (auth.), Stewart Sell (eds.) 📂 Library 📅 1992 🏛 Humana Press 🌐 English

<p>The purpose of this book-the fourth volume of a series on Can cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since the public

📁 marketing for bankers

📂 Library 🌐 English

Human Cancer Markers

📁 Human Cancer Markers

✍ William C. Raschke (auth.), Stewart Sell, Britta Wahren (eds.) 📂 Library 📅 1982 🏛 Humana Press 🌐 English

<p>The ability to diagnose cancer by simple measurement of a serum or tissue' 'marker" has been a goal of medical science for many years. There is ample evidence that tumor cells are different from normal cells and pro duce substances that can be detected by currently available immuno chemical or

Cellular Cancer Markers

📁 Cellular Cancer Markers

✍ Stewart Sell, Carleton T. Garrett (auth.), Carleton T. Garrett MD, PhD, Stewart 📂 Library 📅 1995 🏛 Humana Press 🌐 English

<p>In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers reviewed have been chosen because they are biological

Disease Markers: Cancer Genomics

📁 Disease Markers: Cancer Genomics

✍ Robert L. Strausberg 📂 Library 📅 2002 🌐 English

Human Cytogenetic Cancer Markers

📁 Human Cytogenetic Cancer Markers

✍ Sandra R. Wolman, Stewart Sell, Eric Wolman (auth.), Sandra R. Wolman MD, Stewar 📂 Library 📅 1997 🏛 Humana Press 🌐 English

<p>Human Cytogenetic Cancer Markers provides state-of-the-art reviews of both basic research and clinical applications of the chromosomal markers of cancer. These new markers offer great promise, not only for their clinical utility in diagnosis, prognosis, and disease monitoring, but also for their